The HRI Biodonostia Molecular Diagnostics Platform was set up to cover the demand from hospitals and private centers for different molecular studies on genetic pathologies, using their experience in the new Next-Generation Sequencing (NGS) techniques.
The Platform offers a large range of genetic pathology diagnosis to patients with clinical symptoms suggesting a genetic disease, family members of current patients and prenatal studies on couples that are carriers of any mutation and/or with family record.
The plataform is known to be the Facioscapulohumeral Muscular Dystrophy (FSHD) benchmark center in Spain.
Our platform offers all its resources, technology and knowledge guaranteeing personalized care from a qualified team that will provide relevant, individualized genetic counselling to the specialist clinic of origin.
The response time is given in the services offered section and it is calculated in calendar days from sample arrival in the lab to issuing results. The response time is likely to vary due to external factors such as the time taken by suppliers to provide reactive agents or occasional hitches suffered by the technical resources.
It is a must to provide the following technical and administrative information while ordering the services on offer by the Molecular Diagnostics Platform. Likewise, certain instructions must be followed on sample delivery.
In order to make an enquiry and order diagnostics services, kindly contact the head manager of the Molecular Diagnostics Platform.
FAO. Pilar Camaño González
Phone. +34 943006127
Plataforma de Diagnóstico Molecular
Instituto de Investigación Sanitaria Biodonostia (IIS Biodonostia)
Pº Dr. Begiristain, s/n
20014 Donostia-San Sebastián, Gipuzkoa (España)
08.00-15.00 hours (UTC+01:00)